n
a
v
Portfolio
Genetics
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X Syndrome
Dementia
Chronic Myeloid Leukemia (CML)
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
Contact
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 24, 2012
Asuragen to present at upcoming Association for Molecular Pathology Annual Meeting on Genomic Medicine
Share
March 30, 2012
Asuragen awarded $6.8 million commercialization award from the Cancer Prevention and Research Institute of Texas
Share
March 22, 2012
FDA clears Asuragen’s RNARetain® Pre-analytical RNA Stabilization Device
Share
February 17, 2012
Asuragen launches miRInform® Pancreas Test for Use on Fine Needle Aspirate Specimens of Pancreatic Masses
Share
February 2, 2012
Life Technologies appoints Asuragen as a Certified Service Provider for Ion Torrent’s Personal Genome Machine
Share
Prev
1
…
5
6
7
8
About
About
Leadership Team
Culture and Heritage
News
Upcoming Events
Business Development
Back To
Top